The News Review:

- Rockwell Medical Technologies Inc. Appoints Richard Yocum MD as …
- ra Hirsch Pescovitz MD recommended as UM executive vice …
- invivodata and PR Consulting to Present at International Industry …
- invivodata and PR Consulting to Present at International Industry …
- DATATRAK International Inc. Announces the Return of Chris Wilke …
- Durham’s Cato Research invests in Cordex Pharma
- Antibiotic Combination Defeats Extensively Drug-resistant TB

Rockwell Medical Technologies Inc. Appoints Richard Yocum MD as …
MSNBC
to Vice President of Drug Development and Medical Affairs a newly formed position. Yocum will be responsible for leading the clinical development of Soluble Ferric Pyrophosphate (SFP) the Company’s proprietary iron maintenance product currently progressing through a U. Phase 2 clinical study as well as overseeing all aspects of clinical research and development.

ra Hirsch Pescovitz MD recommended as UM executive vice …
U-M Health System News
Pescovitz is executive associate dean for research affairs at Indiana University School of Medicine where she leads basic and clinical research initiatives. She is also president and CE of Riley Hospital for Children and interim vice president for research administration at Indiana. She succeeds Robert P.

invivodata and PR Consulting to Present at International Industry …
IT News nline
USA; its European headquarters is in London England; and its technology development center is in Scotts Valley Calif. For more information visit. comAbout PR ConsultingPR Consulting a division of invivodata inc. provides consulting services to help clinical research teams effectively develop execute and document patient reported outcome (PR) strategies to support their clinical research objectives.

invivodata and PR Consulting to Present at International Industry …
PR Newswire (press release)
Attendees of this conference which begins April 21 2009 in Naples FL can participate in general PR sessions and various peer-led tracks focused on PR regulatory guidelines and implications industry and scientific trends and best practices for designing and executing ePR systems in clinical research. Additional information on ePRficiency 2009 and other upcoming presentations by invivodata and PR Consulting scientists can be found at.

DATATRAK International Inc. Announces the Return of Chris Wilke …
PR Newswire (press release)
DATATRAK International Inc. is a worldwide technology company focused on the provision of multi-component eClinical solutions and related services for the clinical trials industry. The Company delivers a complete portfolio of software products that were created in order to accelerate clinical research data from investigative sites to clinical trial sponsors and ultimately the FDA faster and more efficiently than manual methods or loosely integrated technologies. DATATRAK’s eClinical software suite can be deployed worldwide through an ASP offering or in a licensed Enterprise Transfer model that fully empowers its clients. The DATATRAK software suite and its earlier versions have successfully supported hundreds of international clinical trials involving thousands of clinical research sites and encompassing tens of thousands of patients in 59 countries. DATATRAK International Inc. ‘s product suite has been utilized in some aspect of the clinical development of 16 drugs and one medical device that have received regulatory approval from either the United States Food and Drug Administration or counterpart European bodies.
Related from Golf-monster: GLF CHANNEL promotes Chris Murvin to senior vice president

Durham’s Cato Research invests in Cordex Pharma
Bizjournals.com
biotechnology firm. The deal calls for Cato Research to handle regulatory work and clinical testing of Cordex’s drugs. Cato would be compensated in part with stock ownership in Cordex.

Antibiotic Combination Defeats Extensively Drug-resistant TB
Science Daily (press release)
assistant dean for clinical research and professor of medicine and of clinical epidemiology and population health at Einstein. Currie is also vice president and medical director for research at Montefiore. He will serve as U.